Human Reproduction, Vol. 9, No. 5, pp. 792-799, 1994
© 1994 European Society of Human Reproduction and Embryology
research-article |
Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors*
Correspondence: 2To whom correspondence should be addressed at: Department of Obstetrics and Gynecology, Women and Infants' Hospital, 101 Dudley Street, Providence, RI 02905, USA
This study was designed to identify clinical predictors for early and late ovarian hyperstimulation syndrome (OHSS). A retrospective analysis of all 592 in-vitro fertilization (IVF) cycles from the programme's inception in 1988 up to March 1993 was performed. Six patients (1.0° of cycles) had moderate or severe OHSS presenting 3–7 days post-human chorionic gonadotrophin (HCG), and four patients (0.7° of cycles) had severe OHSS presenting 12–17 days post-HCG. No patient with early OHSS went on to develop late OHSS, and no patient with late OHSS had demonstrated early OHSS. Stepwise logistic regression showed that early OHSS was predicted by the number of oocytes retrieved (range 18–46) (P= 0.0001) and the oestradiol concentration on the day HCG was given (range 12 122–24 454 pmol/1) (P = 0.0003). Late OHSS was predicted by the number of gestational sacs (range 2–3) on ultrasound 4 weeks after embryo transfer (P = 0.0001) but not by the number of oocytes or oestradiol. Early OHSS was an acute effect of the HCG administered prior to egg retrieval in women with high oestradiol and larger numbers of follicles (range 22–51). Late OHSS was induced by the rising serum concentration of HCG produced by the early pregnancy, and in this series of cases it was associated only with multiple gestation.
Key words: HCG/IVF/multiple gestation/OHSS/prediction
*Abstract presented to the 49th Annual Meeting of the American Fertility Society, Montreal, Quebec, Canada, October 9-14, 1993
1Present address: Department of Gynecology and Obstetrics, The Johns Hopkins Hospital, 600 N. Wolfe Street, Baltimore,MD 21205, USA
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Aramwit, K. Pruksananonda, N. Kasettratat, and K. Jammeechai Risk factors for ovarian hyperstimulation syndrome in Thai patients using gonadotropins for in vitro fertilization Am. J. Health Syst. Pharm., June 15, 2008; 65(12): 1148 - 1153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Pau, I. Alonso-Muriel, R. Gomez, E. Novella, A. Ruiz, J. A. Garcia-Velasco, C. Simon, and A. Pellicer Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome Hum. Reprod., June 1, 2006; 21(6): 1453 - 1460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. De Neubourg and J. Gerris Can we eliminate severe ovarian hyperstimulation syndrome? Comment 2 Hum. Reprod., August 1, 2005; 20(8): 2369 - 2369. [Full Text] [PDF]
|
|
|
|
|
|
E. G. Papanikolaou, H. Tournaye, W. Verpoest, M. Camus, V. Vernaeve, A. Van Steirteghem, and P. Devroey Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile Hum. Reprod., March 1, 2005; 20(3): 636 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Orvieto Can we eliminate severe ovarian hyperstimulation syndrome? Hum. Reprod., February 1, 2005; 20(2): 320 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Daelemans, G. Smits, V. de Maertelaer, S. Costagliola, Y. Englert, G. Vassart, and A. Delbaere Prediction of Severity of Symptoms in Iatrogenic Ovarian Hyperstimulation Syndrome by Follicle-Stimulating Hormone Receptor Ser680Asn Polymorphism J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6310 - 6315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Gomez, I Lima, C Simon, and A Pellicer Administration of low-dose LH induces ovulation and prevents vascular hyperpermeability and vascular endothelial growth factor expression in superovulated rats Reproduction, April 1, 2004; 127(4): 483 - 489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bellver, E. A. Munoz, A. Ballesteros, S. R. Soares, E. Bosch, C. Simon, A. Pellicer, and J. Remohi Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study Hum. Reprod., November 1, 2003; 18(11): 2283 - 2288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bellver, E. Escudero, and A. Pellicer Bilateral partial oophorectomy in the management of severe ovarian hyperstimulation syndrome (OHSS): Ovarian mutilating surgery is not an option in the management of severe OHSS Hum. Reprod., July 1, 2003; 18(7): 1363 - 1367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Gomez, C. Simon, J. Remohi, and A. Pellicer Vascular Endothelial Growth Factor Receptor-2 Activation Induces Vascular Permeability in Hyperstimulated Rats, and this Effect Is Prevented by Receptor Blockade Endocrinology, November 1, 2002; 143(11): 4339 - 4348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.E. Egbase, M. Al Sharhan, and J.G. Grudzinskas 'Early coasting' in patients with polycystic ovarian syndrome is consistent with good clinical outcome Hum. Reprod., May 1, 2002; 17(5): 1212 - 1216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C. Fauser, D. de Jong, F. Olivennes, H. Wramsby, C. Tay, J. Itskovitz-Eldor, and H. G. van Hooren Endocrine Profiles after Triggering of Final Oocyte Maturation with GnRH Agonist after Cotreatment with the GnRH Antagonist Ganirelix during Ovarian Hyperstimulation for in Vitro Fertilization J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 709 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-D. Chen, H.-F. Chen, H.-F. Lu, S.-U. Chen, H.-N. Ho, and Y.-S. Yang Value of serum and follicular fluid cytokine profile in the prediction of moderate to severe ovarian hyperstimulation syndrome Hum. Reprod., May 1, 2000; 15(5): 1037 - 1042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Cil, I. S. Tummon, A. A. House, B. Taylor, G. Hooker, J. Franklin, R. Rankin, and M. Carey A tale of two syndromes: ovarian hyperstimulation and abdominal compartment: Case report Hum. Reprod., May 1, 2000; 15(5): 1058 - 1060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Egbase Severe OHSS: How many cases are preventable? Hum. Reprod., January 1, 2000; 15(1): 8 - 10. [Full Text] [PDF]
|
|
|
|
|
|
A.P. Murdoch and I. Evbuomwan Severe complications of ovarian hyperstimulation syndrome are preventable Hum. Reprod., November 1, 1999; 14(11): 2922 - 2924. [Full Text] [PDF]
|
|
|
|
|
|
R.S. Mathur and J.M. Jenkins Severe OHSS: Patients should be allowed to weigh the morbidity of OHSS against the benefits of parenthood Hum. Reprod., September 1, 1999; 14(9): 2183a - 2185a. [Full Text] [PDF]
|
|